Department of Dermatology and Venerology, Bispebjerg University Hospital, Copenhagen, Denmark.
Division of Dermatology, Faculty of Medicine, University of Alberta, Edmonton, Canada.
Clin Cancer Res. 2019 May 15;25(10):3104-3114. doi: 10.1158/1078-0432.CCR-18-4099. Epub 2019 Feb 26.
Mycosis fungoides is one of the most common types of extranodal T-cell lymphomas, considered to be caused by malignant transformation of the mature T cells residing in the skin. However, some clinical observations such as the multifocal distribution of mycosis fungoides lesions or patterns of relapse after radiotherapy are not readily explainable by the mature T-cell origin theory.
We have performed a detailed analysis of T-cell receptor (TCR) rearrangements in single malignant cells and in biopsies from mycosis fungoides tumors composed of >80% of malignant cells using next-generation sequencing (NGS) to pinpoint the relationship between neoplastic cells in mycosis fungoides. We have also aimed to detect malignant, circulating T-cell by whole blood TCR sequencing.
We found a substantial clonal heterogeneity in the mycosis fungoides samples with regards to TCR, and we demonstrated that lymphoma cells harboring identical TCRγ sequences may harbor different TCRα and β sequences. Lack of absolute TCRα, -β, -γ monoclonality was further confirmed by TCR amplification and sequencing from microdissected lymphoma cells. We have also found the TCR rearrangements characteristic for lymphoma cells in patients' peripheral blood despite the lack of leukemic blood involvement; however, the circulating TCRγ clonotype did not always represent the dominant cutaneous clonotype.
These findings can be explained by a model where malignant transformation takes place during early T-cell development giving rise to circulating premalignant clones, which home to the skin producing clinically apparent lesions of cutaneous lymphoma. Therapeutic strategies in T-cell lymphoma should therefore target those early lymphoma precursor cells.
蕈样肉芽肿是最常见的结外 T 细胞淋巴瘤之一,被认为是由皮肤中成熟 T 细胞的恶性转化引起的。然而,一些临床观察结果,如蕈样肉芽肿病变的多灶性分布或放射治疗后的复发模式,用成熟 T 细胞起源理论很难解释。
我们使用下一代测序(NGS)对蕈样肉芽肿肿瘤的单个恶性细胞和活检进行了详细的 T 细胞受体(TCR)重排分析,这些肿瘤由>80%的恶性细胞组成,以确定蕈样肉芽肿中肿瘤细胞之间的关系。我们还旨在通过全血 TCR 测序检测恶性循环 T 细胞。
我们发现蕈样肉芽肿样本在 TCR 方面存在很大的克隆异质性,并且我们证明了携带相同 TCRγ 序列的淋巴瘤细胞可能携带不同的 TCRα 和β 序列。缺乏绝对的 TCRα、-β、-γ 单克隆性进一步通过从微切割的淋巴瘤细胞中扩增和测序 TCR 得到证实。尽管没有白血病性血液参与,但我们在患者的外周血中也发现了具有淋巴瘤细胞特征的 TCR 重排;然而,循环 TCRγ 克隆型并不总是代表显性皮肤克隆型。
这些发现可以用这样一种模型来解释,即在 T 细胞早期发育过程中发生恶性转化,产生循环的癌前克隆,这些克隆归巢到皮肤,产生明显的皮肤淋巴瘤病变。因此,T 细胞淋巴瘤的治疗策略应该针对那些早期的淋巴瘤前体细胞。